Navigation Links
Vaccination responsible for dramatic fall in Salmonella infections
Date:1/16/2013

Mass poultry vaccination programmes introduced to combat Salmonella infections have led to a dramatic fall in the number of cases since the late 1990s, according to a researcher at the University of Liverpool.

Salmonella are important food-borne pathogens worldwide, causing diarrhoea, vomiting, nausea, fever and abdominal pain. There are currently around 6 million cases of illness from Salmonella across the EU each year, the majority of which are linked to food items such as eggs, chicken, beef, pork, salad vegetables and dairy products.

Between 1981 and 1991, the number of salmonella infections rose by 170% in the UK, driven primarily by an epidemic of Salmonella Enteritidis which peaked in 1993. A raft of control measures were introduced into the poultry industry including movement restrictions, compulsory slaughter and disinfection procedures, as well as a voluntary industry-led vaccination scheme that began in breeding flocks in 1994 and in laying flocks in 1998.

Legislation requiring compulsory slaughter of poultry infected with Salmonella has now been revoked but the mass vaccination of poultry has continued by those breeders subscribing to the Lion Quality Code of Practice and using the Lion Mark on eggs. The code of practice requires mandatory vaccination of all young hens destined to lay Lion eggs against Salmonella, as well as traceability of hens, eggs and feed, a best-before date stamped on shells and hygiene controls at packing stations. Lion eggs now account for around 85% of the total market.

Sarah O'Brien, Professor of Epidemiology and Zoonoses, from the University's Institute of Infection and Global Health, attributes a dramatic fall in the number of Salmonella cases in humans to this mass vaccination programme in poultry.

Professor O'Brien said: "We have seen a marked decline in the number of incidences of Salmonella infection, shown by two significant studies conducted 10 years apart. These studies found that the number of cases fell from 1.6 cases per 1,000 person years for a study conducted from 1993 to 1996 (1) to 0.2 cases per 1,000 person years for the same study conducted from 2008 to 2009 (2).

"In addition, the number of laboratory-confirmed cases of illness dropped from more than 18,000 in 1993 to just 459 in 2010 (3).

"The nature of public health interventions often means that evaluating their impact is complex as they are often implemented simultaneously. The decrease in laboratory confirmed human cases coincides quite closely with the introduction of vaccination programmes in breeder and laying flocks. It is probable that no single measure contributed to the decline in Salmonella cases but the relationship between vaccination programmes and the reduction in human disease is compelling and suggests these programmes have made a major contribution to improving public health."


'/>"/>

Contact: Kate Mizen
kate.mizen@liv.ac.uk
44-015-179-42247
University of Liverpool
Source:Eurekalert

Related medicine news :

1. Thigh Is Safer Vaccination Site Than Arm for Toddlers, Study Finds
2. HPV-associated cancer incidence rates point to needed efforts to increase HPV vaccination coverage
3. BUSM study finds certain subgroups of black women have lower uptake of HPV vaccination
4. More Kids Opting Out of School-Required Vaccinations: Study
5. Childhood Vaccination Rates Remain High, CDC Says
6. Study explores medical exemptions from school vaccination requirements across states
7. Vaccinations Belong on Parents Back-to-School Checklists
8. Hepatitis A vaccination in children under 2 remains effective for 10 years
9. Human papillomavirus types do not replace others after large-scale vaccination
10. Infant Vaccination Delays Triple in Oregon: Study
11. miR-205 can be responsible for breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... ... Health, is now offering treatments for patients with sleep apnea and TMJ disorders. ... for dental and physical health. Dr. Rassouli provides personalized care to reduce the ...
(Date:1/19/2017)... ... January 19, 2017 , ... Sam & Associates Insurance Agency, a full ... clients in the California Bay Area, is launching a charity drive to raise awareness ... Heart disease is the primary killer of adult men and women in America, and ...
(Date:1/19/2017)... ... January 19, 2017 , ... St. Catherine’s Village announced that a limited ... a skilled nursing facility on the grounds of the St. Catherine’s Village campus in ... voted the best nursing home in Mississippi for the second year in a row ...
(Date:1/19/2017)... ... , ... The CHP suggests that California drivers can avoid hydroplaning as well ... increasing the space between themselves and other vehicles, according to a January 3 ... Hassanlou notes that, rain or shine, drivers should always incorporate safe driving practices in ...
(Date:1/19/2017)... ... , ... Sales Focus Inc. (SFI), a Maryland-based sales outsourcing company, announced today ... past 20 years SFI has been recognized as the world’s leader in Intelligent Sales ... the US market. The new clients include: Panacea Pro, Campseekers, Contentmart, Stress Pal, ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... URBANDALE, Iowa , Jan. 18, 2017 /PRNewswire/ ... announced that subsidiary Caretta Therapeutics plans, in the ... product. Venodol, a topical roll-on intended to provide ... to opioid and steroidal analgesics. It was developed ... Reid to commercialize products derived from snake ...
(Date:1/18/2017)... , Jan. 18, 2017  Kratom leaves, from ... family, are often used to prepare tea-like beverages ... several million Americans annually to increase alertness, enhance ... remedy for minor aches and pains. PinneyAssociates, review ... intended to assist FDA and DEA in determining ...
(Date:1/18/2017)... 18, 2017  Dermata Therapeutics, LLC, a biotechnology ... a variety of dermatological diseases, announces dosing the ... a Phase 2 acne rosacea study. DMT210 is ... proinflammatory cytokines in the skin responsible for the ... This clinical trial, DMT210-003, is a ...
Breaking Medicine Technology: